Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
03/2014
03/25/2014CA2594418C N-(heteroaryl)-1h-indole-2-carb0xamide derivatives and their use as vanilloid trpv1 receptor ligands
03/25/2014CA2531020C Cannabinoid receptor modulator
03/20/2014WO2014043246A1 Enoyl reductase inhibitors with antibacterial activity
03/20/2014WO2014042405A1 A novel combination of a host compound and a dopant compound and an organic electroluminescence device comprising the same
03/20/2014WO2014041362A1 Uv radiation cleavable compounds
03/20/2014WO2014041349A1 Tetrahydropyran-4-ylethylamino- or tetrahydropyranyl-4-ethyloxy-pyrimidines or -pyridazines as isoprenylcysteincarboxymethyl transferase inhibitors
03/20/2014WO2014040164A1 Processes for the preparation of 3-alkyl indoles
03/20/2014US20140080843 Methods for inhibiting fascin
03/20/2014US20140080835 Quinazolinone derivatives as parp inhibitors
03/20/2014US20140080829 Pyrimidyl cyclopentanes as akt protein kinase inhibitors
03/20/2014US20140080826 Modulators of atp-binding cassette transporters
03/20/2014US20140080825 Modulators of ATP-binding cassette transporters
03/20/2014US20140080807 Substituted indazole derivatives active as kinase inhibitors
03/20/2014US20140080803 Novel trpv3 modulators
03/20/2014US20140080798 Vegfr3 inhibitors
03/20/2014US20140080790 Heteroarylcarboxylic acid ester derivative
03/20/2014US20140080788 Novel bicyclic nitrogen containing heteroaryl tgr5 receptor modulators
03/20/2014US20140080770 Arylalkylamine compound and process for preparing the same
03/20/2014US20140080768 Prodrugs of dhodh inhibitors and their uses
03/20/2014US20140079784 Aerosolized lfa-1 antagonists for use in localized treatment of immune related disorders
03/20/2014US20140079667 Tetrazolones as inhibitors of fatty acid synthase
03/19/2014EP2707365A1 Hepatitis c virus inhibitors
03/19/2014EP2706993A1 Pharmaceutical compositions comprising neuropilin inhibitors, and their use for the prevention and/or treatment of angiogenic disorders and cancers
03/19/2014CN103649080A Nitrogenated aromatic heterocyclic derivative, and organic electroluminescent element using same
03/19/2014CN103649079A Hepatitis C inhibitors and uses thereof
03/19/2014CN103649077A Sulphonamide derivatives of alicyclic amines for the treatment of central nervous system diseases
03/19/2014CN103649076A Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as trka kinase inhibitors
03/19/2014CN103649074A Substituted azaheterocycles for the treatment of cancer
03/19/2014CN103649073A 17alpha-hydroxylase/c17,20-lyase inhibitors
03/19/2014CN103649068A An intermediate of statin drugs and preparation thereof
03/19/2014CN103649053A Aminomethyl quinolone compounds
03/19/2014CN103648281A Fungicidal alkyl-substituted 2-[2-chloro-4-(4-chloro-phenoxy)-phenyl]-1-[1,2,4]triazol-1-yl-ethanol compounds
03/19/2014CN103642470A Preparation and using methods of diluent for oil-based drilling fluid
03/19/2014CN103641925A Covalent polycompound of water-soluble polysaccharide and taxane compound, and preparation method and medical application of covalent polycompound
03/19/2014CN103641820A Tetrazolium imine coumarins copper ion fluorescence probe and preparation method thereof
03/19/2014CN103641814A 4'-O-substituted isoindoline derivatives and compositions comprising and methods of using the same
03/19/2014CN101952258B Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
03/19/2014CN101910134B Processes for producing cycloalkylcarboxiamido-pyridine benzoic acids
03/18/2014US8674135 Functionalized ionic liquids, and methods of use thereof
03/18/2014US8674100 Inhibitors of C-FMS kinase
03/18/2014US8674006 Black pigment dispersion
03/18/2014US8673921 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride
03/18/2014US8673920 Inhibitors of the renal outer medullary potassium channel
03/18/2014CA2749174C Benzimidazole-4-carboxamide derivatives, their preparation methods, pharmaceutical compositions and their uses
03/13/2014WO2014039769A1 Imidazolin-5-one derivatives useful as fatty acid snthase (fasn) inhibitors for|the treatment of cancer
03/13/2014WO2014039412A1 Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonists
03/13/2014WO2014038867A1 A novel combination of a host compound and a dopant compound and an organic electroluminescence device comprising the same
03/13/2014WO2014038663A1 Method for producing sulfonyl amidine compound
03/13/2014WO2014038623A1 3-(4-piperidyl)-indazole derivative
03/13/2014WO2014037751A1 Pharmacologically active compounds
03/13/2014WO2014037750A1 Inhibitor compounds
03/13/2014WO2014036823A1 Novel preparation method of antithrombosis medicine
03/13/2014WO2013182946A3 Vilazodone hydrobromide, process for its preparation and vilazodone polymorphs
03/13/2014US20140073783 Neprilysin inhibitors
03/13/2014US20140073782 Substituted Quinazoline and Pyrido-Pyrimidine Derivatives
03/13/2014US20140073682 Pyrrolidine triple reuptake inhibitors
03/13/2014US20140073669 4'-o-substituted isoindoline derivatives and compositions comprising and methods of using the same
03/13/2014US20140073666 Compositions and methods for treatment
03/13/2014US20140073661 Heterocyclic compounds and uses thereof
03/13/2014US20140073639 Inhibition of antimicrobial targets with reduced potential for resistance
03/13/2014US20140073636 Novel hydroxy-6-heteroarylphenanthridines and their use as pde4 inhibitors
03/13/2014US20140073629 Alkoxy pyrazoles as soluble guanylate cyclase activators
03/13/2014US20140073627 Bradykinin b1 antagonists
03/13/2014US20140073621 5-alkynyl-pyrimidines
03/12/2014EP2705082A1 5h-furan-2-one derivatives for stabilization of organic material
03/12/2014EP2705030A1 Partially saturated tricyclic compounds and methods of making and using same
03/12/2014EP2704707A1 Novel benzofurane-piperidine compounds
03/12/2014CN103635471A Material for organic electroluminescent elements, and organic electroluminescent element using same
03/12/2014CN103635470A Chromene compound and curable composition
03/12/2014CN103626961A Carbazole unit-containing polymer, preparation method of carbazole unit-containing polymer and organic electroluminescent device
03/12/2014CN103626746A Preparation method of ATPase (adenosine triphosphatase) inhibitor compound
03/12/2014CN103626745A Preparation method for ticagrelor intermediate
03/12/2014CN103626744A Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid
03/12/2014CN103626743A Novel intermediate of ticagrelor and preparation method thereof
03/12/2014CN103626742A Bi-aryl meta-pyrimidine inhibitors of kinases
03/12/2014CN103626713A Aza (oxa)-cyclopentane-2- ketone (thione) compounds, medicine compositions thereof, preparation method and applications
03/12/2014CN103626692A 3,5-diaryl-ylidene piperidone derivatives and application thereof in preparing blood glucose-reducing and fat-reducing medicine
03/12/2014CN102796075B Benzocycloheptenes derivative as well as preparation method and medical application thereof
03/12/2014CN102516217B Compound containing chiral chromanone skeletons and asymmetric synthetic method thereof
03/12/2014CN102325754B Cyclic compound having hetero atom
03/12/2014CN101935303B Broadspectrum substituted benzimidazole sulfonamide HIV protease inhibitors
03/12/2014CN101720318B Quinazolin-oxime derivatives as Hsp90 inhibitors
03/11/2014US8669274 Metalloenzyme inhibitor compounds
03/11/2014CA2784180C Seven-membered ring compound and pharmaceutical use therefor
03/11/2014CA2655801C Therapeutic or prophylactic agent for leukemia
03/11/2014CA2501932C Use of benzimidazole quinolinones for treating cancer
03/06/2014WO2014035712A1 Benzopyrylium compounds
03/06/2014WO2014034898A1 Pyridine derivative and medicine
03/06/2014WO2014034868A1 Method for producing biaryl compound
03/06/2014WO2014034791A1 Organic electroluminescent element
03/06/2014WO2014034584A1 Organic electroluminescent element, illuminator, and display device
03/06/2014WO2014033631A1 N-(3-pyridyl) biarylamides as kinase inhibitors
03/06/2014WO2014033448A1 Pyrazole derivatives as p38 map inhibitors
03/06/2014WO2014032801A1 Fluoromethyl-substituted pyrrole carboxamides
03/06/2014US20140066478 Beta2-Adrenoreceptor Agonists
03/06/2014US20140066476 Modulators of cellular adhesion
03/06/2014US20140066466 Necroptosis Inhibitors and Methods of Use Therefor
03/06/2014US20140066453 Serine/threonine kinase inhibitors
03/06/2014US20140066426 Fluoromethyl-substituted pyrrole carboxamides
03/06/2014US20140066412 Heteroaryl substituted urea modulators of fatty acid amide hydrolase
1 ... 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 ... 694